Skip to content

Decrease in amount of pain killer after surgery

EFFECT OF TRANSVERSALIS FASCIA PLANE BLOCK ON POST OPERATIVE ANALGESIA IN ILIAC CREST BONE GRAFTING FOR UPPER LIMB SURGERY, A TRIPLE BLIND RANDOMISED CONTROLLED TRIAL

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023285
Enrollment
60
Registered
2020-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M248- Other specific joint derangements,not elsewhere classified Health Condition 2: M218- Other specified acquired deformities of limbs

Interventions

Intervention1: Transversalis fascia plane block: After pt. selection and inform consent, the pt. will receive drug A(which will contain 20ml of 0.5m% bupivacaine+1:200000 epinephrine) in USG guided T

Sponsors

Indira Gandhi institute of medical sciencesSheikhpura Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Scheduled for elective upper limb surgery, which can be solely performed under a brachial plexus block,and requiring ICBG

Exclusion criteria

Exclusion criteria: 1)Contraindications to regional blockade (eg. Allergy to local anaesthetic,coagulopathy,malignancy or infection in the area) 2)Pregnancy 3)History of alcohol or drug dependence/abuse 4)History of long term opioid intake or chronic pain disorder. 5)History of significant psychiatric condition that may affect patient assessment. 6)Failure of upper extremity block. 7)Previous iliac crest bone grafting. 8)Inability to informed consent and demands of the study.

Design outcomes

Primary

MeasureTime frame
1)opioid consumption (time frame 24hrs) Opioid consumption in first 24hrs following ICBG. this will measure in terms of mg dose of IV morphine.Timepoint: First 24hrs

Secondary

MeasureTime frame
1)Pain measure 2)Time of block performance 3)ComplicationsTimepoint: First 24hrs

Countries

India

Contacts

Public ContactDr Swati

Indira Gandhi Institute of medical Sciences

dranita2092@gmail.com6201103013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026